Modified blood clots
US10905716B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 16, 2016 |
| Grant date | Feb 2, 2021 |
| Priority date | — |
| Expiry date | Feb 16, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for preparing modified blood clots comprising removal of the cellular content of the blood clots. The invention further provides uses of the modified blood clots as therapeutic agents and as delivery vehicles for cells, bio-molecules and other agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.